Hypoxia frequently mediates chemoresistance and tumor aggressiveness via the induction of HIF-1α in the tumor microenvironment, and targeting HIF-1α is a potential strategy to increase the effect of tumor chemotherapy [47]. Here, HIF1A is linked to neoplasm.